The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012
Permanent link
https://hdl.handle.net/10037/10469Date
2016-06-09Type
Journal articleTidsskriftartikkel
Peer reviewed
Abstract
Background: Results from several recent cohort studies on smoking and breast cancer incidence and mortality suggest that the
burden of smoking on society is underestimated. We estimated the fraction of breast cancer attributable to smoking in the Norwegian Women and Cancer Study, a nationally representative prospective cohort study.
Methods: We followed 130 053 women, aged 34–70 years, who completed a baseline questionnaire between 1991 and 2007, through linkages to national registries through December 2012. We used Cox proportional hazards models to estimate hazard ratios (HRs) with 95% confidence intervals (CIs), while adjusting for confounders. Never smokers, excluding passive smokers, were used as the reference group in all main analyses. We estimated attributable fractions (AFs) % in smokers and in the population (PAFs) % with 95% CIs.
Results: Altogether, 4132 women developed invasive breast cancer, confirmed by histology. Compared with never active, never passive smokers, ever (former and current) smokers had an overall risk of breast cancer that was 21% higher (HR¼1.21; 95% CI¼1.08–1.34). For ever smokers, the AF was 17.3% (95% CI ¼7.4–25.4) and for the population the PAF of breast cancer was 11.9% (95% CI¼5.3–18.1). For passive smokers, the PAF of breast cancer was 3.2% (95% CI¼1.0–5.4). When we applied PAF estimates for ever smoking on the 2907 new breast cancer cases among Norwegian women aged 35þ at diagnosis in 2012, this yielded 345 (95% CI¼154–526) breast cancer cases that could have been avoided in the absence of active smoking that year.
Conclusions: In smokers, one in six and in the population, one in nine breast cancer cases could have been avoided in the absence of active smoking. Our findings support the notion that the global cancer burden due to smoking is substantially underestimated.
Methods: We followed 130 053 women, aged 34–70 years, who completed a baseline questionnaire between 1991 and 2007, through linkages to national registries through December 2012. We used Cox proportional hazards models to estimate hazard ratios (HRs) with 95% confidence intervals (CIs), while adjusting for confounders. Never smokers, excluding passive smokers, were used as the reference group in all main analyses. We estimated attributable fractions (AFs) % in smokers and in the population (PAFs) % with 95% CIs.
Results: Altogether, 4132 women developed invasive breast cancer, confirmed by histology. Compared with never active, never passive smokers, ever (former and current) smokers had an overall risk of breast cancer that was 21% higher (HR¼1.21; 95% CI¼1.08–1.34). For ever smokers, the AF was 17.3% (95% CI ¼7.4–25.4) and for the population the PAF of breast cancer was 11.9% (95% CI¼5.3–18.1). For passive smokers, the PAF of breast cancer was 3.2% (95% CI¼1.0–5.4). When we applied PAF estimates for ever smoking on the 2907 new breast cancer cases among Norwegian women aged 35þ at diagnosis in 2012, this yielded 345 (95% CI¼154–526) breast cancer cases that could have been avoided in the absence of active smoking that year.
Conclusions: In smokers, one in six and in the population, one in nine breast cancer cases could have been avoided in the absence of active smoking. Our findings support the notion that the global cancer burden due to smoking is substantially underestimated.
Description
Published version. Source at http://dx.doi.org/10.1038/bjc.2016.154
Publisher
Cancer Research UKCitation
Gram, I. T., Little, M. A., Lund, E., Braaten, T.: The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012. British Journal of Cancer. 2016;115(5):616-623Metadata
Show full item recordCollections
Related items
Showing items related by title, author, creator and subject.
-
Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and risk of in situ breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Karavasiloglou, Nena; Hüsing, Anika; Masala, Giovanna; van Gils, Carla H.; Fortner, Renée Turzanski; Chang-Claude, Jenny; Huybrechts, Inge; Weiderpass, Elisabete; Gunter, Marc; Arveux, Patrick; Fournier, Agnès; Kvaskoff, Marina; Tjønneland, Anne; Kyrø, Cecilie; Dahm, Christina C.; Vistisen, Helene Tilma; Bakker, Marije F.; Sánchez, María-José; Chirlaque López, María Dolores; Santiuste, Carmen; Ardanaz, Eva; Menéndez, Virginia; Agudo, Antonio; Trichopoulou, Antonia; Karakatsani, Anna; La Vecchia, Carlo; Peppa, Eleni; Palli, Domenico; Agnoli, Claudia; Panico, Salvatore; Tumino, Rosario; Sacerdote, Carlotta; Butt, Salma Tunå; Borgquist, Signe; Skeie, Guri; Schulze, Matthias; Key, Timothy; Khaw, Kay-Tee; Tsilidis, Konstantinos K.; Ellingjord-Dale, Merete; Riboli, Elio; Kaaks, Rudolf; Dossus, Laure; Rohrmann, Sabine; Kühn, Tilman (Journal article; Tidsskriftartikkel; Peer reviewed, 2019-12-02)<i>Background</i> - Even though in situ breast cancer (BCIS) accounts for a large proportion of the breast cancers diagnosed, few studies have investigated potential risk factors for BCIS. Their results suggest that some established risk factors for invasive breast cancer have a similar impact on BCIS risk, but large population-based studies on lifestyle factors and BCIS risk are lacking. Thus, ... -
Diet, dietary supplements and dietary change in cancer survivors and cancer-free persons : the Norwegian Women and Cancer study and the European Prospective Investigation into Cancer and Nutrition
Skeie, Guri (Doctoral thesis; Doktorgradsavhandling, 2009-09-11)This thesis focuses on diet and dietary change in women who have breast or colorectal cancer, compared to cancer-free women in the Norwegian Women and Cancer study (NOWAC; Kvinner og kreft). The use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition (EPIC) is also described. Finally, the association between use of cod liver oil and other supplements and survival ... -
A comprehensive analysis of the androgen receptor gene and risk of breast cancer. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
Cox, David G.; Lund, Eiliv; Blanché, Hélène; Pearce, Celeste L.; Calle, Eugenia E.; Colditz, Graham A.; Pike, Malcolm C.; Albanes, Demetrius; Allen, Naomi E.; Amiano, Pilar; Berglund, Göran; Boeing, Heiner; Buring, Julie; Burtt, Noel; Canzian, Federico; Chanock, Stephen; Flavel-Chapelon, Françoise; Feigelson, Heather Spencer; Freedman, Matthew; Haiman, Christopher A.; Hankinson, Susan E.; Henderson, Brian E.; Hoover, Robert; Hunter, David J.; Kaaks, Rudolf; Kolonel, Laurence; Kraft, Peter; LeMarchand, Loic; Palli, Domenico; Peeters, Petra H.M.; Riboli, Elio; Stram, Daniel O.; Thun, Michael; Tjönneland, Anne; Trichopoulos, Dimitrios; Yeager, Meredith (Journal article; Tidsskriftartikkel; Peer reviewed, 2006-09-20)Introduction Androgens have been hypothesised to influence risk of breast cancer through several possible mechanisms, including their conversion to estradiol or their binding to the oestrogen receptor and/or androgen receptor (AR) in the breast. Here, we report on the results of a large and comprehensive study of the association between genetic variation in the AR gene and risk of breast cancer ...